Načítá se...
Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK(1)) receptor antagonists
Chemotherapy-induced nausea (CIN) has a significant negative impact on the quality of life of cancer patients. The use of 5-hydroxytryptamine-3 (5-HT(3)) receptor antagonists (RAs) has reduced the risk of vomiting, but (except for palonosetron) their effect on nausea, especially delayed nausea, is l...
Uloženo v:
| Vydáno v: | Support Care Cancer |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378744/ https://ncbi.nlm.nih.gov/pubmed/28108820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3585-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|